This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanazawa, N.
Right arrow Articles by Watanabe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanazawa, N.
Right arrow Articles by Watanabe, M.

 Previous Article  |  Next Article 

Journal of Virology, September 2004, p. 9713-9720, Vol. 78, No. 18
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.18.9713-9720.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1

Nobuhiko Kanazawa,1,{dagger} Masayuki Kurosaki,1,{dagger} Naoya Sakamoto,1* Nobuyuki Enomoto,1,2 Yasuhiro Itsui,1 Tsuyoshi Yamashiro,1 Yoko Tanabe,1 Shinya Maekawa,1 Mina Nakagawa,1 Cheng-Hsin Chen,1 Sei Kakinuma,1 Shigeru Oshima,1 Tetsuya Nakamura,1 Takanobu Kato,3 Takaji Wakita,3 and Mamoru Watanabe1

Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University,1 Department of Microbiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo,3 First Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan2

Received 2 February 2004/ Accepted 12 May 2004

Cellular antiviral responses are mediated partly by the expression of interferon-stimulated genes, triggered by viral genomes, their transcripts and replicative intermediates. Persistent replication of a hepatitis C virus (HCV) replicon suggests that the replicon does not elicit cellular innate antiviral responses. In the present study, we investigated regulatory factors of the interferon-mediated antiviral system in cells expressing an HCV replicon. Luciferase reporter assays revealed that the baseline activity of the interferon-stimulated response element (ISRE) was significantly lower in cells harboring the replicon than in naive cells. Among the proteins involved in the IFN/Jak/STAT pathway and in ISRE activity, the expression level of interferon regulatory factor 1 (IRF-1) was found to be significantly lower in cells harboring the replicon. Transfection of an IRF-1 expression construct into cells harboring the replicon caused an increase of ISRE activity, accompanied by suppression of expression of the HCV replicon. Moreover, in cured Huh7 cells from which the HCV replicon had been eliminated, the expression levels of IRF-1 and ISRE activity also were suppressed, demonstrating that the decrease of IRF-1 is attributable, not to active suppression by the viral proteins, but to adaptation of cells that enables replication of the HCV subgenome. The high permissiveness of the cured cells for the replicon was abolished by transgenic supplementation of IRF-1 expression. Taken together, IRF-1 is one of the key host factors that regulate intracellular HCV replication through modulation of interferon-stimulated-gene-mediated antiviral responses.


* Corresponding author. Mailing address: Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81-3-5803-5877. Fax: 81-3-5803-0268. E-mail: nsakamoto.gast{at}tmd.ac.jp.

{dagger} N.K. and M.K. contributed equally to this work.


Journal of Virology, September 2004, p. 9713-9720, Vol. 78, No. 18
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.18.9713-9720.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Tasaka, M., Sakamoto, N., Itakura, Y., Nakagawa, M., Itsui, Y., Sekine-Osajima, Y., Nishimura-Sakurai, Y., Chen, C.-H., Yoneyama, M., Fujita, T., Wakita, T., Maekawa, S., Enomoto, N., Watanabe, M. (2007). Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. J. Gen. Virol. 88: 3323-3333 [Abstract] [Full Text]  
  • Wong, R. T.-Y., Hon, C.-C., Zeng, F., Leung, F. C.-C. (2007). Screening of differentially expressed transcripts in infectious bursal disease virus-induced apoptotic chicken embryonic fibroblasts by using cDNA microarrays. J. Gen. Virol. 88: 1785-1796 [Abstract] [Full Text]  
  • Satterly, N., Tsai, P.-L., van Deursen, J., Nussenzveig, D. R., Wang, Y., Faria, P. A., Levay, A., Levy, D. E., Fontoura, B. M. A. (2007). Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 104: 1853-1858 [Abstract] [Full Text]  
  • Ciccaglione, A. R., Stellacci, E., Marcantonio, C., Muto, V., Equestre, M., Marsili, G., Rapicetta, M., Battistini, A. (2007). Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes. J. Virol. 81: 202-214 [Abstract] [Full Text]  
  • Breiman, A., Vitour, D., Vilasco, M., Ottone, C., Molina, S., Pichard, L., Fournier, C., Delgrange, D., Charneau, P., Duverlie, G., Wychowski, C., Maurel, P., Meurs, E. F. (2006). A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells. J. Gen. Virol. 87: 3587-3598 [Abstract] [Full Text]  
  • Jacobs, J. M., Diamond, D. L., Chan, E. Y., Gritsenko, M. A., Qian, W., Stastna, M., Baas, T., Camp, D. G. II, Carithers, R. L. Jr., Smith, R. D., Katze, M. G. (2005). Proteome Analysis of Liver Cells Expressing a Full-Length Hepatitis C Virus (HCV) Replicon and Biopsy Specimens of Posttransplantation Liver from HCV-Infected Patients. J. Virol. 79: 7558-7569 [Abstract] [Full Text]  
  • Turcotte, K., Gauthier, S., Tuite, A., Mullick, A., Malo, D., Gros, P. (2005). A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. JEM 201: 881-890 [Abstract] [Full Text]